Abstract
The relationship between the size of the primary tumour upon initial treatment and the incidence of distant metastasis during the course of the disease was investigated using data from 2648 breast cancers treated at the Institut Gustave Roussy between 1954 and 1972. This analysis suggests the existence for each tumour of a critical volume (threshold) at which the first remote metastasis is initiated. The correlation between the size of the primary tumour and the probability of metastatic dissemination was assessed as well as the influence on this correlation of two prognostic indicators: histological grade and number of involved lymph nodes. It was found that the threshold volume is strongly correlated with the number of involved lymph nodes and the histological grading.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Koscielny, S., Tubiana, M., Lê, M. et al. Breast cancer: Relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49, 709–715 (1984). https://doi.org/10.1038/bjc.1984.112
Issue Date:
DOI: https://doi.org/10.1038/bjc.1984.112
This article is cited by
-
Breast cancer microenvironment and obesity: challenges for therapy
Cancer and Metastasis Reviews (2022)
-
Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer
Discover Oncology (2022)
-
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
BMC Women's Health (2021)
-
A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer
Scientific Reports (2021)
-
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
Breast Cancer Research and Treatment (2021)